Publicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (12)

2023

  1. In-depth blood immune profiling of Good syndrome patients

    Frontiers in Immunology, Vol. 14

  2. KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1347-1359

2017

  1. Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: Response to disodium cromoglycate and disease outcome

    Allergy, Asthma and Clinical Immunology, Vol. 13, Núm. 1

2015

  1. The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

    Journal of Leukocyte Biology, Vol. 97, Núm. 1, pp. 49-59

2014

  1. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance

    Haematologica, Vol. 99, Núm. 1, pp. 155-162

  2. Flow cytometry in mastocytosis: Utility as a diagnostic and prognostic tool

    Immunology and Allergy Clinics of North America, Vol. 34, Núm. 2, pp. 297-313

2011

  1. CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults

    Leukemia, Vol. 25, Núm. 4, pp. 718-722

2010

  1. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

    Journal of Allergy and Clinical Immunology, Vol. 125, Núm. 6

  2. Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes

    Journal of Allergy and Clinical Immunology, Vol. 125, Núm. 3

2009

  1. Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients

    Journal of Allergy and Clinical Immunology, Vol. 124, Núm. 3, pp. 514-521

  2. Successful treatment with VAD of a myelodysplastic syndrome occurring during the course of a smoldering multiple myeloma

    Leukemia Research

2006

  1. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients

    Blood, Vol. 108, Núm. 7, pp. 2366-2372